The stock of Fulgent Genetics Inc (NASDAQ:FLGT) is a huge mover today! The stock increased 6.65% or $0.62 on November 29, hitting $9.94. About 119,498 shares traded hands or 212.43% up from the average. Fulgent Genetics Inc (NASDAQ:FLGT) has risen 6.00% since October 30, 2016 and is uptrending. It has outperformed by 0.74% the S&P500.
The move comes after 6 months positive chart setup for the $176.84M company. It was reported on Nov, 29 by Barchart.com. We have $10.54 PT which if reached, will make NASDAQ:FLGT worth $10.61M more.
Analysts await Fulgent Genetics Inc (NASDAQ:FLGT) to report earnings on February, 13. FLGT’s profit will be $889,537 for 49.70 P/E if the $0.05 EPS becomes a reality. After $-0.44 actual earnings per share reported by Fulgent Genetics Inc for the previous quarter, Wall Street now forecasts -111.36% EPS growth.
Fulgent Genetics Inc (NASDAQ:FLGT) Ratings Coverage
Out of 2 analysts covering Fulgent Genetics (NASDAQ:FLGT), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Fulgent Genetics has been the topic of 2 analyst reports since October 24, 2016 according to StockzIntelligence Inc. The rating was initiated by Piper Jaffray on Monday, October 24 with “Overweight”. The firm has “Outperform” rating given on Monday, October 24 by Credit Suisse.
According to Zacks Investment Research, “Fulgent Genetics, Inc. is a technology company. It provide genetic testing services to physicians with clinically actionable diagnostic information. The Company’s technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics, Inc. is headquartered in Temple City, California.”
More notable recent Fulgent Genetics Inc (NASDAQ:FLGT) news were published by: Seekingalpha.com which released: “IPO Preview: Fulgent Genetics, Inc.” on September 27, 2016, also Marketwatch.com with their article: “/quotes/zigman/3870025/realtime” published on September 05, 2016, Globenewswire.com published: “Fulgent Genetics, Inc. to Announce Third Quarter 2016 Financial Results on …” on October 26, 2016. More interesting news about Fulgent Genetics Inc (NASDAQ:FLGT) were released by: Globenewswire.com and their article: “Fulgent Genetics, Inc. Announces Pricing of Initial Public Offering” published on September 28, 2016 as well as Globenewswire.com‘s news article titled: “Fulgent Genetics, Inc. to Participate in Fireside Chat at the 28th Annual …” with publication date: November 15, 2016.
FLGT Company Profile
Fulgent Genetics, Inc. is a technology company. The Firm offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Firm has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of September 02, 2016, the Company’s test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.